IPN-01194

N/A

Report date: 2024/04/10 17:46:12
NME

Base Information

Drug NameIPN-01194
Drug Alias NameIPN01194IPN-01194AGV-1805
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors
TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsSquamous Cell Carcinoma of Head and Neck +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAGV Discovery
China Registration ClassN/A

Develop Information

Active CompaniesIpsen
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsSquamous Cell Carcinoma of Head and Neck +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A